Business Standard

Page 9 - Serum Institute Of India

Govt increases gap between two doses of Covishield to 12-16 weeks

States told to ensure adherence to revised schedule

Govt increases gap between two doses of Covishield to 12-16 weeks
Updated On : 14 May 2021 | 12:56 AM IST

Delhi govt urges Serum Institute to 'come to rescue' and provide Covishield

To this, the SII said they are doing their best to meet countrywide vaccine requirements.

Delhi govt urges Serum Institute to 'come to rescue' and provide Covishield
Updated On : 13 May 2021 | 7:49 PM IST

Serum Institute has promised 15 mn vaccine doses to Maharashtra: Minister

Serum Institute of India CEO Adar Poonawalla has promised Chief Minister Uddhav Thackeray to deliver 15 million doses of Covishield to Maharashtra after May 20, said the state health minister

Serum Institute has promised 15 mn vaccine doses to Maharashtra: Minister
Updated On : 13 May 2021 | 8:24 AM IST

Avoid unrealistic Covid-19 vaccine expectations: Harsh Vardhan to states

The health minister was holding a meeting with eight states that have been showing a higher number of daily cases, positivity rate and mortality

Avoid unrealistic Covid-19 vaccine expectations: Harsh Vardhan to states
Updated On : 13 May 2021 | 12:30 AM IST

Maharashtra, Karnataka suspend Covid-19 vaccination for 18-44 age group

Delhi's Deputy Chief Minister Manish Sisodia accused the Centre of blocking supplies to the state.

Maharashtra, Karnataka suspend Covid-19 vaccination for 18-44 age group
Updated On : 13 May 2021 | 12:14 AM IST

Will raise monthly production of vaccines to 100 mn doses by August: Serum

Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September. The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield, being manufactured by the Pune-based Serum Institute of India, are currently being used in India's inoculation drive against coronavirus. Dr V Krishna Mohan, the Whole-time Director of Bharat Biotech, is learnt to have conveyed to the government that the production of Covaxin would be raised to 3.32 crore in July, and to 7.82 crore in August which will be maintained in September too. Similarly, Prakash Kum

Will raise monthly production of vaccines to 100 mn doses by August: Serum
Updated On : 13 May 2021 | 12:11 AM IST

After just Rs 18,000 cr profits in a decade, Serum, Bharat Biotech may earn big with Covid

For both companies, the pandemic presents a once-in-a-lifetime opportunity to earn hundreds of crores of rupees that could be ploughed back to fund further research and capacity expansion

After just Rs 18,000 cr profits in a decade, Serum, Bharat Biotech may earn big with Covid
Updated On : 10 May 2021 | 10:27 AM IST

India and Serum, engulfed in second wave, stumble over their Covid promises

Forget saving humanity, the unfolding tragedy has made it clear that India - even with the world's largest vaccine maker at its disposal - cannot save itself

India and Serum, engulfed in second wave, stumble over their Covid promises
Updated On : 08 May 2021 | 7:27 PM IST

Maharashtra, UP, Delhi getting lower vaccine doses than needed: SBI report

Tamil Nadu, Haryana, Punjab, Bihar and North Eastern States are the states where vaccination wastage is 'quite high', the report said

Maharashtra, UP, Delhi getting lower vaccine doses than needed: SBI report
Updated On : 07 May 2021 | 10:32 PM IST

Plea in Bombay High Court seeks Z+ security for Adar Poonawalla, his family

A writ petition on Wednesday has been filed in the Bombay High Court seeking Z plus security for Serum Institute of India CEO Adar Poonawalla and his family

Plea in Bombay High Court seeks Z+ security for Adar Poonawalla, his family
Updated On : 06 May 2021 | 9:21 AM IST

Best of BS Opinion: Stigmatised capital, TMC's election success, and more

Here are the best of Business Standard's opinion pieces for Wednesday

Best of BS Opinion: Stigmatised capital, TMC's election success, and more
Updated On : 05 May 2021 | 6:30 AM IST

Stigmatised capital

Poonawalla's comments reveal the pitfalls of doing business in India

Stigmatised capital
Updated On : 04 May 2021 | 10:21 PM IST

Serum Institute of India leads cross-sector Indian investments into UK

The Serum Institute of India will invest 240 million pounds in the UK to expand its vaccine business

Serum Institute of India leads cross-sector Indian investments into UK
Updated On : 04 May 2021 | 7:03 PM IST

Covid-19 2nd wave: Reports of no fresh vaccine order incorrect, says govt

Business Standard had reported in Monday's edition of the newspaper that the Centre had not yet placed fresh orders with the vaccine manufacturers. We stand corrected.

Covid-19 2nd wave: Reports of no fresh vaccine order incorrect, says govt
Updated On : 04 May 2021 | 1:29 PM IST

Have got full advance for 110 mn doses, says Serum CEO Poonawalla

Poonawalla, who left for the UK recently, said in an interview that he was getting threatening calls from powerful people in India for delivering vaccine

Have got full advance for 110 mn doses, says Serum CEO Poonawalla
Updated On : 04 May 2021 | 7:16 AM IST

UK-India summit: Serum Institute set to invest 240 million pound in Britain

The Serum Institute of India will invest 240 million pound in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs

UK-India summit: Serum Institute set to invest 240 million pound in Britain
Updated On : 04 May 2021 | 6:22 AM IST

File complaint about threats: Maharashtra govt to SII CEO Poonawalla

A Maharashtra minister on Monday said Serum Institute of India's CEO Adar Poonawalla should lodge a police complaint in connection with the alleged threats that he has received

File complaint about threats: Maharashtra govt to SII CEO Poonawalla
Updated On : 03 May 2021 | 3:49 PM IST

Serum CEO Adar Poonawalla says will return to India in a few days

On his stay in the UK, the Serum Institute of India (SII) head said that he "had an excellent meeting" with all partners and stakeholders in that country

Serum CEO Adar Poonawalla says will return to India in a few days
Updated On : 03 May 2021 | 12:45 AM IST

Getting aggressive calls from powerful Indians: SII CEO on vaccine pressure

Adar Poonawalla told UK's The Times in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield

Getting aggressive calls from powerful Indians: SII CEO on vaccine pressure
Updated On : 01 May 2021 | 8:58 PM IST

Serum Institute plans to start vaccine production outside India: Report

Adar Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July

Serum Institute plans to start vaccine production outside India: Report
Updated On : 01 May 2021 | 8:00 AM IST